These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10641227)

  • 1. Hepatitis B vaccine recombinant (Janssen/Medeva). Hepagene.
    Drugs R D; 1999 Sep; 2(3):201-2. PubMed ID: 10641227
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B vaccine recombinant (bio-technology general). BioHepB, Sci-B-Vac.
    Drugs R D; 1999 Sep; 2(3):199-200. PubMed ID: 10641226
    [No Abstract]   [Full Text] [Related]  

  • 3. Do we need better hepatitis B vaccines?
    Gerlich WH
    Indian J Med Res; 2017 Apr; 145(4):414-419. PubMed ID: 28862172
    [No Abstract]   [Full Text] [Related]  

  • 4. [Russian recombinant vaccine against hepatitis B (results of controlled trials)].
    Pavlova LI; Gorbunov MA; Borisova VN; Krasil'nikov IV; Noskova AV; Lytsar' BN; Skvortsov SV; Beliakova EA; Iakovleva IM; Korovin IuP; Bel'chenko AV; Titov IA; Budanov MV
    Vopr Virusol; 1996; 41(4):170-2. PubMed ID: 8999672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vaccines against viral hepatitis B: results and prospects].
    Mukomolov SL
    Tr Inst Im Pastera; 1992; 67():103-15. PubMed ID: 8539762
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunogenicity of indigenous recombinant hepatitis B vaccine in infants following a 0, 1, 2-month vaccination schedule.
    Kumar TS; Abraham P; Raghuraman S; Cherian T
    Indian Pediatr; 2000 Jan; 37(1):75-80. PubMed ID: 10745392
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepagene (PowderJect).
    Jones T
    Curr Opin Investig Drugs; 2002 Jul; 3(7):987-91. PubMed ID: 12186276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic recombinant hepatitis B vaccine in patients undergoing orthotopic liver transplantation.
    Berner J; Kadian M; Post J; Miller C; Schwartz M; Conn M; Borcich A
    Transplant Proc; 1993 Apr; 25(2):1751-2. PubMed ID: 8470152
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunogenicity of a low dose of indigenously developed recombinant hepatitis-B vaccine in neonates and infants.
    Rao MN; Joshi N; Habibullah CM
    Indian Pediatr; 1999 Jun; 36(6):581-3. PubMed ID: 10736587
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to hepatitis B virus vaccine in patients transplanted for HBV-related liver disease under specific gammaglobulin prophylaxis.
    Bárcena R; Fernandez-Braso M; Urman J; López-San Román A; del Campo S; Moreno N; Lopez P; Garcia M; Plaza MP; Garcia Plaza A
    Transplant Proc; 1999 Sep; 31(6):2459-60. PubMed ID: 10500670
    [No Abstract]   [Full Text] [Related]  

  • 11. Responsiveness to intradermal recombinant hepatitis B vaccine.
    CDR (Lond Engl Wkly); 1991 Oct; 1(43):198. PubMed ID: 1669886
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis B virus vaccine in chronic kidney disease: improved immunogenicity by adjuvants? A meta-analysis of randomized trials.
    Fabrizi F; Dixit V; Messa P; Martin P
    Vaccine; 2012 Mar; 30(13):2295-300. PubMed ID: 22285268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low response to hepatitis B virus vaccine in Costa Rican health-care workers.
    Taylor L; García Z; Herrera G; Luftig RB; Visona KA
    Hepatology; 1998 Feb; 27(2):637. PubMed ID: 9462669
    [No Abstract]   [Full Text] [Related]  

  • 14. [The evaluation on immunogenicity of hepatitis B vaccine].
    Li HM; Liang ZL; Zhang HY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):378-81. PubMed ID: 15231155
    [No Abstract]   [Full Text] [Related]  

  • 15. A novel, recombinant triple antigen hepatitis B vaccine (Hepacare).
    Page M; Jones CD; Bailey C
    Intervirology; 2001; 44(2-3):88-97. PubMed ID: 11509870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute myelitis after immunization against hepatitis B with recombinant vaccine].
    Senejoux A; Roulot D; Belin C; Tsakiris L; Rautureau J; Coste T
    Gastroenterol Clin Biol; 1996; 20(4):401-2. PubMed ID: 8758508
    [No Abstract]   [Full Text] [Related]  

  • 17. How to improve anti-hepatitis B vaccination.
    Gafter U
    Nephron Clin Pract; 2006; 103(3):c87-8. PubMed ID: 16534236
    [No Abstract]   [Full Text] [Related]  

  • 18. Response to recombinant hepatitis B vaccine in children and adolescents with chronic renal failure.
    Watkins SL; Alexander SR; Brewer ED; Hesley TM; West DJ; Chan IS; Mendelman P; Bailey SM; Burns JL; Hogg RJ;
    Am J Kidney Dis; 2002 Aug; 40(2):365-72. PubMed ID: 12148110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of the antigenicity and immunogenicity of a new hepatitis B vaccine using a panel of monoclonal antibodies.
    Waters JA; Bailey C; Love C; Thomas HC
    J Med Virol; 1998 Jan; 54(1):1-6. PubMed ID: 9443102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with a yeast-derived hepatitis B vaccine.
    Safary A; Andre FE
    J Chemother; 1989 Jul; 1(4 Suppl):1096-8. PubMed ID: 16312787
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.